These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 21511540

  • 1. Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis.
    Chitnis AS, Aparasu RR, Chen H, Johnson ML.
    Res Social Adm Pharm; 2012; 8(2):145-56. PubMed ID: 21511540
    [Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure.
    Chitnis AS, Aparasu RR, Chen H, Johnson ML.
    J Comp Eff Res; 2012 Mar; 1(2):195-206. PubMed ID: 24237377
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study.
    Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Frankenstein L, Clark AL.
    Eur Heart J Cardiovasc Pharmacother; 2018 Apr 01; 4(2):82-92. PubMed ID: 28475676
    [Abstract] [Full Text] [Related]

  • 4. Mortality and morbidity of non-systolic heart failure treated with angiotensin-converting enzyme inhibitors: a propensity-adjusted case-control study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Almenara J, Gomez F.
    Int J Cardiol; 2010 Mar 18; 139(3):276-82. PubMed ID: 19064293
    [Abstract] [Full Text] [Related]

  • 5. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Levy PD, Nandyal D, Welch RD, Sun JL, Pieper K, Ghali JK, Fonarow GC, Gheorghiade M, O'Connor CM.
    Am Heart J; 2010 Feb 18; 159(2):222-230.e2. PubMed ID: 20152220
    [Abstract] [Full Text] [Related]

  • 6. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 7. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD, Ikem RT, Adigun AQ, Akintomide AO, Balogun MO, Ajayi AA.
    Cent Afr J Med; 1996 Aug 20; 42(8):253-5. PubMed ID: 8990572
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival of non-elderly patients with severe heart failure treated with angiotensin-converting enzyme inhibitors assessment of treatment with captopril and enalapril survival study (ACESS).
    Huang CM, Young MS.
    Circ J; 2002 Oct 20; 66(10):886-90. PubMed ID: 12381079
    [Abstract] [Full Text] [Related]

  • 9. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG, Athyros VG, Papageorgiou AA, Skeberis VM, Basayiannis EC, Boudoulas H.
    Coron Artery Dis; 1997 Oct 20; 8(8-9):517-24. PubMed ID: 9431480
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 20; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 11. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C, Elstein E, Le Lorier J, Suissa S.
    CMAJ; 1999 Aug 10; 161(3):255-60. PubMed ID: 10463046
    [Abstract] [Full Text] [Related]

  • 12. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Aug 10; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 13. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
    Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U, RIKS-HIA Group.
    Am J Cardiol; 2010 May 01; 105(9):1229-34. PubMed ID: 20403471
    [Abstract] [Full Text] [Related]

  • 14. Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.
    Tu K, Mamdani M, Kopp A, Lee D.
    Am J Cardiol; 2005 Jan 15; 95(2):283-6. PubMed ID: 15642572
    [Abstract] [Full Text] [Related]

  • 15. Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
    Giles TD.
    Z Kardiol; 1991 Jan 15; 80 Suppl 2():35-9. PubMed ID: 1850941
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA, Hussein GM, Hamza EA.
    Saudi Med J; 2004 Aug 15; 25(8):1060-5. PubMed ID: 15322598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.